Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies

Human Pathology

Volumn 43, Issue 9, 2012, Pages 1376-1385

  Bai, Haibo ^a   Gayyed, Mariana F ^a,b   Lam Himlin, Dora M ^c   Klein, Alison P ^a   Nayar, Suresh K ^a   Xu, Yang ^a,d   Khan, Mehtab ^a   Argani, Pedram ^a   Pan, Duojia ^a   Anders, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Minia University   (Egypt)

^c MAYO CLINIC   (United States)

^d ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Cholangiocarcinoma; Hepatocellular carcinoma; Survivin; Yes associated protein

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN; TRANSCRIPTION FACTOR YAP1; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LIVER; LIVER NEOPLASMS; MICE; MICE, TRANSGENIC; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 84864281802     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.12.001     Document Type: Article

References (35)

1. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576 (Pubitemid 46890874)
2. C.W. Hammill, and L.L. Wong Intrahepatic cholangiocarcinoma: a malignancy of increasing importance J Am Coll Surg 207 2008 594 603
3. D. Pan The hippo signaling pathway in development and cancer Dev Cell 19 2010 491 505
4. J. Dong, G. Feldmann, and J. Huang Elucidation of a universal size-control mechanism in Drosophila and mammals Cell 130 2007 1120 1133 (Pubitemid 47410268)
5. F.D. Camargo, S. Gokhale, and J.B. Johnnidis YAP1 increases organ size and expands undifferentiated progenitor cells Curr Biol 17 2007 2054 2060 (Pubitemid 350180465)
6. K.P. Lee, J.H. Lee, and T.S. Kim The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc Natl Acad Sci USA 107 2010 8248 8253
7. H. Song, K.K. Mak, and L. Topol Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression Proc Natl Acad Sci USA 107 2010 1431 1436
8. N. Zhang, H. Bai, and K.K. David The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals Dev Cell 19 2010 27 38
9. D. Zhou, C. Conrad, and F. Xia Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438
10. M.Z. Xu, T.J. Yao, and N.P. Lee Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer 115 2009 4576 4585
11. X. Zhang, J. George, and S. Deb The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene Oncogene 30 2011 2810 2822
12. Y. Wang, Q. Dong, and Q. Zhang Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer Cancer Sci 101 2010 1279 1285
13. A.A. Steinhardt, M.F. Gayyed, and A.P. Klein Expression of Yes-associated protein in common solid tumors Hum Pathol 39 2008 1582 1589
14. B.A. Orr, H. Bai, and Y. Odia Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth J Neuropathol Exp Neurol 70 2011 568 577
15. M.D. Bashyam, R. Bair, and Y.H. Kim Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer Neoplasia 7 2005 556 562 (Pubitemid 40967756)
16. Z. Dai, W.G. Zhu, and C.D. Morrison A comprehensive search for DNA amplification in lung cancer identifies inhibitors of apoptosis cIAP1 and cIAP2 as candidate oncogenes Hum Mol Genet 12 2003 791 801 (Pubitemid 36416965)
17. L. Fernandez, P.A. Northcott, and J. Dalton YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Genes Dev 23 2009 2729 2741
18. I. Imoto, Z.Q. Yang, and A. Pimkhaokham Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas Cancer Res 61 2001 6629 6634 (Pubitemid 32896476)
19. M. Overholtzer, J. Zhang, and G.A. Smolen Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc Natl Acad Sci USA 103 2006 12405 12410 (Pubitemid 44267272)
20. Snijders A.M., Schmidt B.L., and Fridlyand J. Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma Oncogene 24 2005 4232 5353
21. L. Zender, M.S. Spector, and W. Xue Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267 (Pubitemid 43929093)
22. Zhao B., Ye X., and Yu J. TEAD mediates YAP-dependent gene induction and growth control Genes Dev 22 2008 1962 1971 (Pubitemid 352008643)
23. J. Zhang, J.Y. Ji, and M. Yu YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway Nat Cell Biol 11 2009 1444 1450
24. M.Z. Xu, S.W. Chan, and A.M. Liu AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma Oncogene 30 2011 1229 1240
25. M.M. Javle, D. Tan, and J. Yu Nuclear survivin expression predicts poor outcome in cholangiocarcinoma Hepatogastroenterology 51 2004 1653 1657 (Pubitemid 39389751)
26. K. Obama, K. Ura, and M. Li Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma Hepatology 41 2005 1339 1348 (Pubitemid 40770287)
27. A.C. Fields, G. Cotsonis, and D. Sexton Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome Mod Pathol 17 2004 1378 1385 (Pubitemid 39472993)
28. T. Ito, K. Shiraki, and K. Sugimoto Survivin promotes cell proliferation in human hepatocellular carcinoma Hepatology 31 2000 1080 1085 (Pubitemid 30233232)
29. Z.Q. Zou, Y.P. Ding, and B. Long Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma Hepatogastroenterology 57 2010 1285 1290
30. S. Benhamouche, M. Curto, and I. Saotome Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver Genes Dev 24 2010 1718 1730
31. L. Lu, Y. Li, and S.M. Kim Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Proc Natl Acad Sci USA 107 2010 1437 1442
32. H. Li, A. Wolfe, and S. Septer Deregulation of Hippo kinase signalling in human hepatic malignancies Liver Int 2011
33. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat Med 3 1997 917 921 (Pubitemid 27353455)
34. D.C. Altieri The case for survivin as a regulator of microtubule dynamics and cell-death decisions Curr Opin Cell Biol 18 2006 609 615 (Pubitemid 44692469)
35. C.H. Cheung, L. Cheng, and K.Y. Chang Investigations of survivin: the past, present and future Front Biosci 16 2011 952 961